American Association for Cancer Research

SHERPA: White

People

  1. Aghajanian
    Aghajanian
  2. Rosales
    Rosales
  3. Kelsen
    Kelsen
  4. Norton
    Norton
  5. Rosen
    Rosen
  6. Seshan
    Seshan
  7. Brown
    Brown
  8. De Stanchina
    De Stanchina
  9. Fleisher
    Fleisher
  10. Giri
    Giri

Groups

  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (19)
  3. GDMT, Medicine (13)
  4. Gynecologic Medicine Service (13)
  5. Gynecology Disease Management Team (13)
  6. Breast Medicine Service (5)
  7. Center for Pancreatic Cancer Research (5)
  8. Melanoma Disease Management Team (5)
  9. Epidemiology and Biostatistics (4)
  10. GSK Faculty (4)
Search Within
  1. "David Spriggs"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (4)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (19)
  3. GDMT, Medicine (13)
  4. Gynecologic Medicine Service (13)
  5. Gynecology Disease Management Team (13)
  6. Breast Medicine Service (5)

More Groups

People
  1. David Spriggs (43)
  2. Carol Aghajanian (12)
  3. Gary Schwartz (9)
  4. Nestor Rosales (9)
  5. Amreen Husain (6)
  6. Xiu Yan (6)

More People

Years
  1. 2022 (1)
  2. 2017 (1)
  3. 2013 (1)
  4. 2012 (1)
  5. 2011 (1)
  6. 2002 (1)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (38)
  2. Cancer Immunology Research (2)
  3. Molecular Cancer Therapeutics (2)
  4. Cancer Discovery (1)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual fluorescence isogenic synthetic lethal kinase screen and high-content secondary screening for MUC16/CA125-selective agents
    Journal Article

    Rao, T. D.; Xu, M.; Eng, S.; Yang, G.; Manson, R.; Rosales, N.; Kumar, R.; Veillard, I. E.; Zhou, Q.; Iasonos, A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Armored CAR T cells genetically modified to secrete IL-12 show enhanced efficacy and overcome a hostile tumor microenvironment in mouse ovarian peritoneal carcinomatosis
    Meeting Abstract

    Yeku, O.; Purdon, T.; Spriggs, D.; Brentjens, R.
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Effect of montanide and Poly-ICLC adjuvant on human self/tumor antigen-specific CD4(+) T cells in phase I overlapping long peptide vaccine trial
    Journal Article

    Tsuji, T.; Sabbatini, P.; Jungbluth, A. A.; Ritter, E.; Pan, L.; Ritter, G.; Ferran, L.; Spriggs, D.; Salazar, A. M.; Gnjatic, S.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents
    Journal Article

    Rao, T. D. ; Rosales, N.; Spriggs, D. R.
    Molecular Cancer Therapeutics (2011)

    Fulltext@MSK | Save
  • Autoregulation of TNF-alpha in human breast cancer cells: Defining a cis-element in the 3'-UTR RNA of TNF-alpha as the target for HuR binding
    Meeting Abstract

    Zhao, Z.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Effects of the 3'-untranslated region of human TNF-a and the analogues of thalidomide on the expression of luciferase reporter gene in human epithelial carcinoma cell
    Meeting Abstract

    Tian, H.; Daud, A.; Bornmann, W.; Spriggs, D. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • BRCA1 is post-transcriptionally upregulated by estrogen in MCF-7 human breast cancer cells
    Meeting Abstract

    Zhao, Z.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kaubisch, A.; O'reilly, E.; Sharma, S.; Endres, S.; Welch, M.; Tong, W.; Spriggs, D.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • A comparison of gene expression analyses in SKOV-3 wild-type and resistant ovarian carcinoma cells following treatment with cisplatin and a non-cross-resistant platinum analogue, ZD-0473
    Meeting Abstract

    Dizon, D. S.; Yan, X. J.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save